Literature DB >> 3106126

Impact of metabolic control in progression of clinical diabetic nephropathy.

G Nyberg, G Blohmé, G Nordén.   

Abstract

Renal clearance of 51Cr-EDTA as a measure of glomerular filtration rate was followed prospectively for 21 months in 18 Type 1 (insulin-dependent) patients with juvenile-onset diabetes and nephropathy. Hypertension was treated aggressively, attaining a mean blood pressure of 154/88 mmHg in the supine and 126/82 mmHg in the standing position. The mean glycosylated haemoglobin value (HbA1c) during the observation period was found to correlate well with the mean of random blood glucose values (r = 0.72). It also correlated to the rate of glomerular filtration rate decline over time, whether the latter was calculated as slope coefficient for all available data (r = -0.52, p less than 0.05) or based on the first and last observations only (r = -0.57, p less than 0.05). In a multiple linear stepwise regression analysis also including mean arterial blood pressure, the correlation between glomerular filtration rate decline and HbA1c was significant at p less than 0.01; this explained one-third of the progression, while mean arterial pressure could not be shown to contribute. It is concluded that hyperglycaemia, contrary to the general belief, is a risk factor for the progression of clinical diabetic nephropathy with reduced glomerular filtration rate.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3106126     DOI: 10.1007/bf00274576

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  21 in total

1.  A prospective study of glomerular filtration rate and arterial blood pressure in insulin-dependent diabetics with diabetic nephropathy.

Authors:  H H Parving; U M Smidt; B Friisberg; V Bonnevie-Nielsen; A R Andersen
Journal:  Diabetologia       Date:  1981-04       Impact factor: 10.122

2.  Glycosylated haemoglobin in renal failure.

Authors:  M J de Boer; K Miedema; A F Casparie
Journal:  Diabetologia       Date:  1980-06       Impact factor: 10.122

3.  Hemoglobin carbamylation in uremia.

Authors:  R Flückiger; W Harmon; W Meier; S Loo; K H Gabbay
Journal:  N Engl J Med       Date:  1981-04-02       Impact factor: 91.245

4.  Determination of glomerular filtration rate in advanced renal insufficiency.

Authors:  R Jagenburg; P O Attman; M Aurell; H Bucht
Journal:  Scand J Urol Nephrol       Date:  1978

5.  A platelet aggregation inhibitor--ticlopidine--in diabetic nephropathy: a randomized double blind study.

Authors:  G Nyberg; O Larsson; N G Westberg; M Aurell; R Jagenburg; G Blohmé
Journal:  Clin Nephrol       Date:  1984-03       Impact factor: 0.975

6.  Metabolic and blood pressure monitoring in diabetic renal failure.

Authors:  J Berglund; L E Lins; P E Lins
Journal:  Acta Med Scand       Date:  1985

7.  Early aggressive antihypertensive treatment reduces rate of decline in kidney function in diabetic nephropathy.

Authors:  H H Parving; A R Andersen; U M Smidt; P A Svendsen
Journal:  Lancet       Date:  1983-05-28       Impact factor: 79.321

Review 8.  The kidney in diabetes.

Authors:  S M Mauer; M W Steffes; D M Brown
Journal:  Am J Med       Date:  1981-03       Impact factor: 4.965

9.  Long-term antihypertensive treatment inhibiting progression of diabetic nephropathy.

Authors:  C E Mogensen
Journal:  Br Med J (Clin Res Ed)       Date:  1982-09-11

10.  Long term correction of hyperglycaemia and progression of renal failure in insulin dependent diabetes.

Authors:  G C Viberti; R W Bilous; D Mackintosh; J J Bending; H Keen
Journal:  Br Med J (Clin Res Ed)       Date:  1983-02-19
View more
  12 in total

1.  Effect of improved metabolic control on loss of kidney function in type 1 (insulin-dependent) diabetic patients: an update of the Steno studies.

Authors:  B Feldt-Rasmussen; E R Mathiesen; T Jensen; T Lauritzen; T Deckert
Journal:  Diabetologia       Date:  1991-03       Impact factor: 10.122

2.  Improved survival in patients with diabetic nephropathy.

Authors:  E R Mathiesen; K Borch-Johnsen; D V Jensen; T Deckert
Journal:  Diabetologia       Date:  1989-12       Impact factor: 10.122

3.  Metabolic control and progression of diabetic nephropathy.

Authors:  G Viberti; H Keen; R Dodds; J J Bending
Journal:  Diabetologia       Date:  1987-07       Impact factor: 10.122

4.  Glucose Control and Diabetic Complications: Is tight control of IDDM justified?

Authors:  S Lubin
Journal:  Can Fam Physician       Date:  1991-06       Impact factor: 3.275

5.  Prognosis in diabetic nephropathy.

Authors:  H H Parving; E Hommel
Journal:  BMJ       Date:  1989-07-22

6.  Prevalence of microalbuminuria and its correlates among diabetic patients attending diabetic clinic at National Guard Hospital in Alhasa.

Authors:  Aneesah A AlFehaid
Journal:  J Family Community Med       Date:  2017 Jan-Apr

Review 7.  [Protection of renal function in diabetics].

Authors:  C Hasslacher
Journal:  Internist (Berl)       Date:  2007-07       Impact factor: 0.743

Review 8.  The relationship between glucose control and the development and progression of diabetic nephropathy.

Authors:  Carrie A Phillips; Mark E Molitch
Journal:  Curr Diab Rep       Date:  2002-12       Impact factor: 4.810

Review 9.  Cost-effective strategies in the prevention of diabetic nephropathy.

Authors:  Jonathan D Rippin; Anthony H Barnett; Stephen C Bain
Journal:  Pharmacoeconomics       Date:  2004       Impact factor: 4.981

10.  Adjusting the 17β-Estradiol-to-Androgen Ratio Ameliorates Diabetic Nephropathy.

Authors:  Akari Inada; Oogi Inada; Nobuharu L Fujii; Seiho Nagafuchi; Hitoshi Katsuta; Yohichi Yasunami; Takeshi Matsubara; Hidenori Arai; Atsushi Fukatsu; Yo-Ichi Nabeshima
Journal:  J Am Soc Nephrol       Date:  2016-03-03       Impact factor: 10.121

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.